These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1496878)

  • 41. Differential Antibody Responses to Outer Membrane Proteins Contribute to Differential Immune Protections between Live and Inactivated Vibrio parahemolyticus.
    Liu X; Yang MJ; Wang SN; Xu D; Li H; Peng XX
    J Proteome Res; 2018 Sep; 17(9):2987-2994. PubMed ID: 30095909
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intranasal administration of a two-dose adjuvanted multi-antigen TMV-subunit conjugate vaccine fully protects mice against Francisella tularensis LVS challenge.
    McCormick AA; Shakeel A; Yi C; Kaur H; Mansour AM; Bakshi CS
    PLoS One; 2018; 13(4):e0194614. PubMed ID: 29684046
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nature of protective immunity to Francisella tularensis.
    Tärnvik A
    Rev Infect Dis; 1989; 11(3):440-51. PubMed ID: 2665002
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Application of luminol-dependent chemiluminescence to assay opsonizing antibodies to procyclic forms of Trypanosoma congolense in the sera of dogs experimentally infected with heterologous stocks.
    Olaho-Mukani W; Winter P; Dörflinger W; Hörchner F; Ahmed JS
    Trop Med Parasitol; 1990 Jun; 41(2):213-6. PubMed ID: 2382102
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Defects in opsonization activity of the serum of patients with chronic arthritis].
    Böhm U; Merétey K; Seszták M; Hodinka L; Koó E; Zahumenszky Z
    Z Rheumatol; 1988; 47(3):161-5. PubMed ID: 3213263
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunization with heat-killed Francisella tularensis LVS elicits protective antibody-mediated immunity.
    Lavine CL; Clinton SR; Angelova-Fischer I; Marion TN; Bina XR; Bina JE; Whitt MA; Miller MA
    Eur J Immunol; 2007 Nov; 37(11):3007-20. PubMed ID: 17960662
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Downmodulation of vaccine-induced immunity and protection against the intracellular bacterium Francisella tularensis by the inhibitory receptor FcγRIIB.
    Franz BJ; Li Y; Bitsaktsis C; Iglesias BV; Pham G; Sunagar R; Kumar S; Gosselin EJ
    J Immunol Res; 2015; 2015():840842. PubMed ID: 25961064
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Francisella tularensis LVS evades killing by human neutrophils via inhibition of the respiratory burst and phagosome escape.
    McCaffrey RL; Allen LA
    J Leukoc Biol; 2006 Dec; 80(6):1224-30. PubMed ID: 16908516
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The antibody response of animals to a corpuscular meningococcal group-B preparation with different methods of immunization].
    Aleksakhina NN; Basnak'ian IA; Kolenko VM; Borovkova VM; Saraeva LV; Stukalova NV; Karabak VI
    Zh Mikrobiol Epidemiol Immunobiol; 1992; (7-8):30-4. PubMed ID: 1466168
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of an immunochromatographic test for rapid and reliable serodiagnosis of human tularemia and detection of Francisella tularensis-specific antibodies in sera from different mammalian species.
    Splettstoesser W; Guglielmo-Viret V; Seibold E; Thullier P
    J Clin Microbiol; 2010 May; 48(5):1629-34. PubMed ID: 20220165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis.
    Fulop M; Mastroeni P; Green M; Titball RW
    Vaccine; 2001 Aug; 19(31):4465-72. PubMed ID: 11483272
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Enhanced antitumor resistance in rats immunized with a tularemia vaccine].
    Zil'fian VN; Kumkumadzhian VA; Nersesian AK; Fichidzhian BS
    Eksp Onkol; 1986; 8(1):60-2. PubMed ID: 3753929
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative assessment of human neutrophil chemiluminescence induced by opsonized Escherichia coli K-12.
    Jungi TW; Schmid A; Morell A; Spaeth PJ; Peterhans E
    Zentralbl Bakteriol Mikrobiol Hyg A; 1989 Jan; 270(3):406-17. PubMed ID: 2648712
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic engineering of Francisella tularensis LVS for use as a novel live vaccine platform against Pseudomonas aeruginosa infections.
    Robinson CM; Kobe BN; Schmitt DM; Phair B; Gilson T; Jung JY; Roberts L; Liao J; Camerlengo C; Chang B; Davis M; Figurski L; Sindeldecker D; Horzempa J
    Bioengineered; 2015; 6(2):82-8. PubMed ID: 25617059
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The cytogenetic action of x-ray irradiation on the myelokaryocytes of rats immunized with a tularemia vaccine].
    Nersesian AK; Kumkumadzhian VA; Zil'fian VN
    Tsitol Genet; 1989; 23(6):15-8. PubMed ID: 2623763
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Francisella tularensis resistance to bactericidal action of normal human serum.
    Sorokin VM; Pavlovich NV; Prozorova LA
    FEMS Immunol Med Microbiol; 1996 Mar; 13(3):249-52. PubMed ID: 8861038
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vaccination strategies for Francisella tularensis.
    Isherwood KE; Titball RW; Davies DH; Felgner PL; Morrow WJ
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1403-14. PubMed ID: 15919131
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activation of phagocyte oxidative metabolism by opsonized Plasmodium falciparum merozoites.
    Lunel F; Descamps-Latscha B; Druilhe P
    Acta Trop; 1990 Feb; 47(2):61-8. PubMed ID: 1969702
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background.
    Chen W; Shen H; Webb A; KuoLee R; Conlan JW
    Vaccine; 2003 Sep; 21(25-26):3690-700. PubMed ID: 12922099
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The use if Francisella tularensis lipopolysaccharide in the dot solid phase enzyme immunoassay].
    Aronova NV; Pavlovich NV
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (5):75-8. PubMed ID: 11220974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.